Literature DB >> 16353959

Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.

Jochen Haas1, M N V Ravi Kumar, Gerrit Borchard, Udo Bakowsky, Claus-Michael Lehr.   

Abstract

The purpose of this research was to prepare poly-(epsilon-caprolactone) (PCL) particles by an emulsion-diffusion-evaporation method using a blend of poly-(vinyl alcohol) and chitosan derivatives as stabilizers. The chitosan derivatives used were chitosan hydrochloride and trimethyl chitosans (TMC) with varying degrees of quaternization. Particle characteristics-size, zeta potential, surface morphology, cytotoxicity, and transfection efficiency-were investigated. The developed method yields PCL nanoparticles in the size range of 250 to 300 nm with a positive surface charge (2.5 to 6.8 mV). The cytotoxicity was found to be moderate and virtually independent of the stabilizers' concentration with the exception of the highly quaternized TMC (degree of substitution 66%) being significantly more toxic. In immobilization experiments with gel electrophoresis, it could be shown that these cationic nanoparticles (NP) form stable complexes with DNA at a NP:DNA ratio of 3:1. These nanoplexes showed a significantly higher transfection efficiency on COS-1 cells than naked DNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353959      PMCID: PMC2750407          DOI: 10.1208/pt060106

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  28 in total

1.  Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.

Authors:  Y Capan; B H Woo; S Gebrekidan; S Ahmed; P P DeLuca
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 2.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

Authors:  Thomas Merdan; Jindrich Kopecek; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

3.  Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation.

Authors:  J G Smith; T Wedeking; J H Vernachio; H Way; R W Niven
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

4.  Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents.

Authors:  M N V Ravi Kumar; S S Mohapatra; X Kong; P K Jena; U Bakowsky; C M Lehr
Journal:  J Nanosci Nanotechnol       Date:  2004-11

5.  Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures.

Authors:  Bogdan I Florea; Clare Meaney; Hans E Junginger; Gerrit Borchard
Journal:  AAPS PharmSci       Date:  2002

6.  A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity.

Authors:  D Fischer; T Bieber; Y Li; H P Elsässer; T Kissel
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

7.  Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo.

Authors:  M N V Ravi Kumar; M Sameti; S S Mohapatra; X Kong; R F Lockey; U Bakowsky; G Lindenblatt; H Schmidt; C M Lehr
Journal:  J Nanosci Nanotechnol       Date:  2004-09

8.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Authors:  Vladimir P Torchilin; Tatyana S Levchenko; Ram Rammohan; Natalia Volodina; Brigitte Papahadjopoulos-Sternberg; Gerard G M D'Souza
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

9.  Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation.

Authors:  Zhengrong Cui; Russell J Mumper
Journal:  Bioconjug Chem       Date:  2002 Nov-Dec       Impact factor: 4.774

10.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids.

Authors:  C W Pouton; P Lucas; B J Thomas; A N Uduehi; D A Milroy; S H Moss
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

View more
  7 in total

1.  Biodegradable starch derivatives with tunable charge density-synthesis, characterization, and transfection efficiency.

Authors:  Carolin Thiele; Brigitta Loretz; Claus-Michael Lehr
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

Review 2.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

3.  In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system.

Authors:  Brigitta Loretz; Andreas Bernkop-Schnürch
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

Review 4.  Trimethyl chitosan and its applications in drug delivery.

Authors:  V K Mourya; Nazma N Inamdar
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

5.  Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan.

Authors:  Sergio Cafaggi; Eleonora Russo; Rossana Stefani; Brunella Parodi; Gabriele Caviglioli; Greta Sillo; Angela Bisio; Cinzia Aiello; Maurizio Viale
Journal:  Invest New Drugs       Date:  2009-12-29       Impact factor: 3.850

Review 6.  Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies.

Authors:  Nashwa Osman; Kan Kaneko; Valeria Carini; Imran Saleem
Journal:  Expert Opin Drug Deliv       Date:  2018-07-26       Impact factor: 6.648

7.  Signal amplification strategy using gold/N-trimethyl chitosan/iron oxide magnetic composite nanoparticles as a tracer tag for high-sensitive electrochemical detection.

Authors:  Hanieh Shirazi; Anita Ahmadi; Maedeh Darzianiazizi; Susan Kashanian; Soheila Kashanian; Kobra Omidfar
Journal:  IET Nanobiotechnol       Date:  2016-02       Impact factor: 1.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.